Delivery Order SPE2DB20D7059-SPE2DB24FQMW4

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ADACEL TDAP VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $2,906.34 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 31, 2024, with a completion date of June 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Adacel TDAP syringes (0.5mL) to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2021, with a ceiling value of $36,168.00 and a completion date of September 28, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that is a critical supplier of pharmaceutical...
This federal contract award is for the delivery of 4564387960 ADACEL TDAP SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $13,512.66, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 24, 2024. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Adacel TDAP syringes (0.5 mL) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract, valued at $13,367.34, is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Adacel Tdap syringes in 0.5 mL quantities. The $15,784.80 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that serves as a critical supplier to federal healthcare programs. The contract has an ultimate completion date of July 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Adacel TDAP syringes (0.5mL) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,616.80, is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,272.40 firm-fixed-price delivery order is for the provision of 4566378192 Adacel TDAP syringes. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of 4562961839 ADACEL TDAP SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The $3,946.50 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 4, 2023 and was awarded on December 1, 2023. This award is a child contract under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of ADACEL TDAP SYRINGE 0.5ML, a pharmaceutical product, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $36,168.00 and runs through August 13, 2021. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award is for the delivery of ADACEL TDAP SYRINGE 0.5ML medical supplies to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $27,869.50 and has a firm fixed price pricing type. It is a delivery order contract with a completion date of February 13, 2024. The contract does not have a set-aside designation, indicating it was awarded...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQMW4
    Delivery Order

This federal contract award is for the delivery of Adacel TDAP syringes (0.5 ml) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 13, 2024, with a ceiling value of $1,272.40. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 16, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/21/25, 10:00 AM